Literature DB >> 6806361

Detection of an altered I-A beta polypeptide in the murine Ir mutant, B6.C-h-2bm12.

D R Lee, T H Hansen, S E Cullen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6806361

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

Review 1.  Structural variation among major histocompatibility complex class-II genes which predispose to autoimmunity.

Authors:  G T Nepom
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.

Authors:  B S Nepom; G T Nepom; E Mickelson; P Antonelli; J A Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

3.  Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition.

Authors:  W W Kwok; E Mickelson; S Masewicz; E C Milner; J Hansen; G T Nepom
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

4.  Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant.

Authors:  L Mengle-Gaw; S Conner; H O McDevitt; C G Fathman
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

5.  A class II gene conversion event defines an antigen-specific Ir gene epitope.

Authors:  P S Hochman; B T Huber
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

6.  The I-Ab mutant B6.C-H-2bm12 allows definition of multiple T cell epitopes on I-A molecules.

Authors:  B N Beck; P A Nelson; C G Fathman
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

7.  Graft-vs.-host-associated immune suppression is activated by recognition of allogeneic murine I-A antigens.

Authors:  G M Shearer; R B Levy
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.